Voisard Asset Management Group, Inc. Poseida Therapeutics, Inc. Transaction History
Voisard Asset Management Group, Inc.
- $205 Billion
- Q2 2024
A detailed history of Voisard Asset Management Group, Inc. transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, Voisard Asset Management Group, Inc. holds 270 shares of PSTX stock, worth $704. This represents 0.0% of its overall portfolio holdings.
Number of Shares
270
Previous 270
-0.0%
Holding current value
$704
Previous $862,000
8.47%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding PSTX
# of Institutions
96Shares Held
38.2MCall Options Held
417KPut Options Held
42.7K-
Pentwater Capital Management LP Naples, FL5.98MShares$15.6 Million0.23% of portfolio
-
Black Rock Inc. New York, NY4.91MShares$12.8 Million0.0% of portfolio
-
Boxer Capital, LLC San Diego, CA4.48MShares$11.7 Million0.73% of portfolio
-
Silverarc Capital Management, LLC3.61MShares$9.42 Million2.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.41MShares$8.89 Million0.0% of portfolio
About Poseida Therapeutics, Inc.
- Ticker PSTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 85,775,600
- Market Cap $224M
- Description
- Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...